The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference155 articles.
1. Atherosclerosis—an inflammatory disease;Ross;N Engl J Med,1999
2. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque;Wilcox;Proc Natl Acad Sci U S A,1989
3. Tissue-factor antigen and activity in human coronary atherosclerotic plaques;Ardissino;Lancet,1997
4. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients;Falciani;Thromb Haemost,1998
5. Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study;Morange;J Thromb Haemost,2007
Cited by 84 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cardiovascular disease and thrombosis: Intersections with the immune system, inflammation, and the coagulation system;Annales Pharmaceutiques Françaises;2024-08
2. Plasma proteomics for prediction of subclinical coronary artery calcifications in primary prevention;American Heart Journal;2024-05
3. Tissue Factor Pathway Inhibitor and Interleukin-1 Receptor Levels in COVID-19;Thrombosis and Haemostasis;2024-04-27
4. Causal Effects of COVID-19 on the Risk of Thrombosis: A Two-Sample Mendel Randomization Study;Thrombosis and Haemostasis;2024-02-07
5. Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer;Haematologica;2023-10-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3